An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00510211

Enrollment

1131

Registered

2007-08-01

Start date

2007-04-30

Completion date

2009-05-31

Last updated

2009-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Schizophrenia

Brief summary

The primary objective of this study is to assess the proportion of schizophrenic patients and the proportion of bipolar patients who discontinue olanzapine within 12 months of treatment in outpatient, ambulatory or community settings

Interventions

DRUGolanzapine

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* patients suffering from schizophrenic or schizoaffective disorders based on the disease diagnostic criteria DSM IV and being prescribed olanzapine during the 45 preceding days. * patients suffering from bipolar disorders based on the disease diagnostic criteria DSM IV and being prescribed olanzapine during the 45 preceding days for one of the following: * moderate or severe manic episode * relapse prevention in patients with bipolar disorder

Exclusion criteria

* current treatment with any investigational drug or procedure at entry or during the whole study * hypersensitivity to olanzapine * patients with known narrow angle glaucoma risk

Countries

France, Germany, Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026